Chapter 12: Āyurveda in the Colonial and Modern World¶
kṛtsno hi loko buddhimatām ācāryaḥ śatruś cābuddhimatām
For the wise the whole world is a teacher; for the foolish, an enemy.
— Caraka Saṃhitā, Vimānasthāna 8.14
12.1 Introduction¶
The Āyurveda practised today is not simply the medicine of Caraka and Suśruta carried unchanged into the present. It is the product of two centuries of encounter with Western biomedicine: of colonial neglect and selective interest, of nationalist revival, of the making of colleges, pharmacopoeias and a pharmaceutical industry, of state recognition after independence, and, more recently, of a global market in “wellness”. Historians and anthropologists have studied this history closely (Leslie 1976; Leslie and Young 1992; Arnold 2000; Ernst 2002; Langford 2002; Alter 2005; Wujastyk and Smith 2008; Banerjee 2009). This chapter outlines it, and then asks what modern research has and has not shown, and what safety questions the use of Ayurvedic medicines raises.
12.2 The Colonial Encounter¶
12.2.1 Early Exchanges¶
In the sixteenth and seventeenth centuries European physicians and naturalists in India learned eagerly from Indian practitioners, as the works of Garcia da Orta and the Hortus Malabaricus show (Chapter 11). Indian drugs entered European pharmacopoeias, and in the eighteenth century European surgeons in India observed Indian practices, such as the operation for rebuilding the nose reported in 1794 (Chapter 4) and inoculation against smallpox, which was practised in Bengal before the introduction of vaccination.
12.2.2 The Native Medical Institution and Its Closure¶
In 1822 the East India Company government in Calcutta founded the Native Medical Institution to train Indians as medical assistants for its army and dispensaries. Teaching was in Hindustani, and Western medicine was taught alongside Indian medicine; classes in Āyurveda were also held at the Sanskrit College, and in Unani at the Calcutta Madrasa. The experiment was short-lived. In 1835, following the decision of Governor-General Bentinck’s government to support only Western learning in English, the Native Medical Institution and the indigenous medical classes were abolished and the Calcutta Medical College was founded to teach Western medicine alone. Madhusudan Gupta, who had taught Āyurveda at the Sanskrit College, moved to the new college and in 1836 performed the first human dissection there—an event later celebrated as a break with tradition, although Suśruta had himself prescribed dissection (Arnold 2000).
From then on, the colonial state recognised and regulated only Western-trained practitioners. Āyurveda and Unani lost official patronage and access to public institutions, though they continued to be practised by the great majority of healers and used by the great majority of Indians.
12.2.3 Revival¶
In the later nineteenth century Āyurveda was reorganised by its own practitioners. Sanskrit medical texts were printed for the first time, many in Calcutta and Bombay, making the classics widely available. Bengali kavirājs, such as Gaṅgādhara Rāy, wrote new commentaries and trained large numbers of students. Ayurvedic pharmacies began to manufacture medicines on an industrial scale—Dabur in Calcutta from 1884 and the Arya Vaidya Sala at Kottakkal from 1902 are well-known early examples—and to sell them through advertisements and by post. Practitioners founded associations, among them the All-India Ayurvedic Congress (1907), journals and colleges.
Some Indian rulers supported Āyurveda before the British provinces did. The state of Travancore opened a school of Āyurveda at Thiruvananthapuram in 1889, which later became a government college, and Mysore and other princely states also founded Āyurvedic schools and dispensaries in the early twentieth century. In British India, private colleges were founded by practitioners’ associations and philanthropists, and in 1927 Banaras Hindu University, under Madan Mohan Malaviya, opened an Āyurvedic college that taught both Sanskrit texts and modern sciences.
The revival was closely linked to nationalism. Āyurveda was presented as an Indian science, equal or superior to Western medicine, whose decline was due to foreign rule. Its leaders disagreed, however, about how it should relate to Western medicine. Some argued for “pure” (śuddha) Āyurveda taught from the Sanskrit texts; others for an “integrated” curriculum that included modern anatomy, physiology and pathology. The debate, analysed by Charles Leslie in a classic essay (Leslie 1976), has shaped Āyurvedic education ever since. Nationalist leaders were not uncritical. Mahatma Gandhi, while sympathetic to indigenous medicine and opposed to much of Western medical practice, told Āyurvedic and Unani physicians that they had neglected research and relied too much on the authority of old texts. Provincial governments, under pressure from the nationalist movement, began to support indigenous medicine in the 1920s, beginning with Madras.
12.2.4 The Usman Committee¶
The first full official inquiry into the Indian systems was made in Madras. In 1921 the government of the Madras Presidency, then run in its “transferred” departments by ministers of the Justice Party under the reforms of 1919, appointed a committee on the indigenous systems of medicine. Its chairman was Muhammad Usman, and its secretary was G. Srinivasa Murti, a physician with a Western medical qualification who became one of the most articulate defenders of Indian medicine. The committee sent a questionnaire to practitioners and scholars across India and printed their replies in its report of 1923, together with Srinivasa Murti’s long memorandum on the scientific character of Āyurveda, Siddha and Unani.
The report argued that the indigenous systems were rational, that they served most of the population, and that the state should support them by founding schools, registering qualified practitioners and encouraging research. Its recommendations led to the opening of a government school of Indian medicine in Madras in the mid-1920s, which taught Āyurveda, Siddha and Unani together with Western subjects (Chapter 11). The replies to the questionnaire are an important source for the state of Indian medicine at the time. The questions the committee posed—whether the Indian systems should be taught in their own terms or alongside modern science, and how the state should recognise their practitioners—dominated the next half-century.
12.2.5 New Textbooks and Colleges¶
The colleges of the revival needed textbooks, and one of the most ambitious answers came from Calcutta. Gaṇanāth Sen (1877–1944), a kavirāj who had studied Western medicine as well as the Sanskrit texts, published from 1913 the Pratyakṣaśārīra, “the body as directly seen”. It is an anatomy written in Sanskrit that follows modern anatomy and coins Sanskrit terms for structures the classical texts do not name. He followed it with the Siddhāntanidāna, a work on pathology in the same spirit. Sen’s books set out to show that Sanskrit could carry modern science, and that an Āyurvedic physician could know the body as precisely as a Western-trained doctor without ceasing to be a vaidya; they turned Suśruta’s call for direct observation (Chapter 4) into a curriculum. Projit Bihari Mukharji has studied this generation of Bengali physicians, who adopted the thermometer and other small instruments, and modern anatomy, while reworking them within Āyurvedic ideas, and he describes the result as a “braided” science rather than a simple borrowing (Mukharji 2016). In an earlier study he showed how Bengali practitioners of Western medicine (ḍākṭārī) used print and the medical market to make that medicine their own, in competition with the kavirājs for the same patients (Mukharji 2009). In the same years Jāminībhūṣaṇ Rāy founded the Aṣṭāṅga Āyurveda Vidyālaya in Calcutta, one of several colleges in which students learned the Sanskrit texts alongside dissection and clinical work in an attached hospital. In Kerala, P. S. Vāriyar, the founder of the Arya Vaidya Sala at Kottakkal, also founded a school to train physicians in a regular course.
In north India the revival took a different colour. Rachel Berger has shown how in the United Provinces Āyurveda became tied to the Hindi movement and to Hindu nationalist politics, how its advocates sought state recognition in the provincial legislatures, and how regulation turned on the question of who could call himself a vaidya (Berger 2013). In the Punjab, Kavita Sivaramakrishnan has traced how practitioners recast their medicine through print, associations and competition with Unani and Western medicine, and how questions of language and religious community shaped the result (Sivaramakrishnan 2006).
12.2.6 Registration¶
From the 1910s the provinces of British India registered doctors trained in Western medicine, and so excluded indigenous practitioners from official recognition (Chapter 11). The associations of vaidyas and ḥakīms answered by seeking registers of their own. During the 1920s and 1930s several provinces and princely states set up boards or faculties of Indian medicine that registered practitioners, recognised colleges and held examinations. Registration gave status and some protection to college-trained vaidyas and ḥakīms. It also turned into “unqualified” practitioners the many hereditary physicians who had learned in a family or from a single teacher and held no diploma. The same process pushed further to the margins the midwives, bonesetters, snakebite healers and other local practitioners described in Chapter 11, who had never belonged to the learned systems at all.
12.2.7 “Pure” and “Integrated” Āyurveda¶
The debate between śuddha and integrated Āyurveda was fiercest between the 1940s and the 1960s. Its best-known champion on the “pure” side was Pandit Shiv Sharma, the son of a royal physician of Patiala, who had taught at the Dayanand Ayurvedic College in Lahore, later worked in Bombay, and became a leading figure of the All-India Ayurvedic Congress. In his book The System of Āyurveda (Bombay, 1929) and in many later addresses he argued that Āyurveda was a complete science that should be developed from its own principles, and that the integrated colleges produced graduates who were neither true vaidyas nor competent modern doctors and who drifted into practising Western medicine. The integrationists answered that no physician, of whatever system, could ignore anatomy, physiology, pathology and pharmacology, and that the classical theory had to be tested and supplemented. Paul Brass’s study of Āyurvedic education in Uttar Pradesh shows how these positions were bound up with the politics of language, religion and professional interest, and how governments swung between them (Brass 1972). The two camps shared more than they admitted. Both accepted the college, the examination, the diploma and the register as the proper forms of a modern medical profession, and both changed Āyurveda in the process of defending it.
12.2.8 Indigenous Drugs and Colonial Science¶
Even as the colonial state withdrew support from Indian practitioners, it took an interest in Indian drugs as possible cheap substitutes for imported medicines and as sources of new ones. Officials compiled catalogues of Indian medicinal plants, and the Pharmacopoeia of India of 1868 included a number of Indian drugs. In the twentieth century, scientific study of these drugs was organised by Indian scientists. At the Calcutta School of Tropical Medicine, founded in 1921, Ram Nath Chopra led a long programme of research on Indian medicinal plants and published Indigenous Drugs of India (Chopra 1933), which tried to separate the useful from the useless by laboratory and clinical study. After independence, the Central Drug Research Institute at Lucknow (1951) and other laboratories screened large numbers of plants. These programmes yielded much knowledge but few new drugs; reserpine (below) was the outstanding success.
12.3 Āyurveda in Independent India¶
After independence the Indian state gave Āyurveda and the other “Indian systems of medicine” official recognition, while making Western medicine the basis of the public health system. A series of committees considered their place: the Chopra Committee (1948) recommended integrating them with modern medicine; later committees debated standards of education and practice (Table 12.1).
| Year | Event |
|---|---|
| 1923 | Report of the Madras committee on the indigenous systems (Usman Committee) |
| 1927 | Āyurvedic college founded at Banaras Hindu University |
| 1948 | Report of the Committee on Indigenous Systems of Medicine (Chopra Committee) |
| 1954 | Drugs and Magic Remedies (Objectionable Advertisements) Act prohibits advertisements claiming to cure specified diseases |
| 1967 | Gujarat Ayurved University, Jamnagar |
| 1970 | Indian Medicine Central Council Act; Central Council of Indian Medicine set up to regulate education and practice |
| 1978 | Central Council for Research in Ayurveda and Siddha constituted from an earlier combined council (renamed the Central Council for Research in Ayurvedic Sciences when Siddha received its own council in 2010) |
| 1995 | Department of Indian Systems of Medicine and Homoeopathy in the Ministry of Health |
| 2003 | Department renamed AYUSH |
| 2014 | Ministry of AYUSH created |
| 2016 | First National Ayurveda Day |
| 2017 | All India Institute of Ayurveda, New Delhi, inaugurated |
| 2020 | National Commission for Indian System of Medicine Act replaces the Central Council of Indian Medicine |
| 2022 | WHO Global Centre for Traditional Medicine established at Jamnagar |
12.3.1 Committees and Curricula, 1946–1970¶
The Health Survey and Development Committee chaired by Joseph Bhore, whose report of 1946 set out the plan for India’s public health services, gave the indigenous systems little attention. A separate Committee on Indigenous Systems of Medicine, chaired by Ram Nath Chopra, the pharmacologist whose work on Indian drugs is described above, reported in 1948. It recommended a “synthesis” of Indian and Western medicine through integrated training, research on Indian drugs and the inclusion of indigenous practitioners in the health services. Research was given an institutional home at Jamnagar in Saurashtra, where a research institute and, in the mid-1950s, a postgraduate training centre in Āyurveda were set up; Jamnagar later became the seat of the Gujarat Ayurved University (Table 12.1).
Further committees, chaired by D. T. Dave (1955) and K. N. Udupa (1958), examined the standards of teaching and practice. For a time the central and several state governments supported courses in “pure” Āyurveda alongside the integrated colleges, under pressure from the śuddha camp. The Indian Medicine Central Council Act of 1970 brought this period of experiment to an end. The Central Council of Indian Medicine set a common minimum curriculum and kept a central register, and the degree course that resulted, described below, keeps the classical texts and the modern subjects side by side. The questions of the 1920s were thus settled administratively rather than intellectually, and they continue to be argued.
12.3.2 Homoeopathy, Naturopathy and Yoga¶
Two of the systems now grouped with Āyurveda under AYUSH did not originate in India but took deep root there. Homoeopathy, devised by the German physician Samuel Hahnemann at the end of the eighteenth century, reached India in the early nineteenth century and spread rapidly in Bengal, where the physician Mahendralal Sircar adopted it in the 1860s. It was given statutory recognition by the Homoeopathy Central Council Act of 1973, and India now has more homoeopathic practitioners than any other country. Systematic reviews, among them a comprehensive assessment by Australia’s National Health and Medical Research Council, have found no reliable evidence that homoeopathic remedies, which are usually diluted beyond the point at which any molecule of the original substance remains, work better than placebo (National Health and Medical Research Council 2015). Naturopathy, or “nature cure”, also came from Europe; Mahatma Gandhi was a lifelong advocate of it and founded a nature-cure centre at Uruli Kanchan near Pune in 1946. Yoga therapy developed at institutions such as Kaivalyadhama at Lonavla, founded by Swami Kuvalayananda in 1924 (see Volume 5 of this series). Their place in the same ministry as Āyurveda is an administrative grouping of the “non-allopathic” systems, not a sign of a shared history.
12.3.3 Āyurveda in the Health System Today¶
From the 2000s the government began to bring AYUSH practitioners into the public health system on a larger scale. Under the National Rural Health Mission, launched in 2005, AYUSH doctors were posted to primary health centres and community health centres, often alongside or in place of doctors of modern medicine, and the Ayushman Bharat programme of 2018 included AYUSH health and wellness centres. These policies have been defended as a way of extending health care to underserved areas and criticised as a substitute for training and posting enough doctors of modern medicine.
India today has several hundred Āyurvedic colleges, which award a five-and-a-half-year degree (B.A.M.S.) that includes modern anatomy, physiology and pathology as well as the classical texts, and postgraduate degrees in the various branches. Hundreds of thousands of registered practitioners work in government dispensaries and hospitals, in private practice and in industry. Many Āyurvedic graduates in fact practise modern medicine, especially in rural areas where qualified doctors are scarce—a long-standing and contested feature of Indian health care. The courts have repeatedly been asked to rule on such “cross-practice”. In Poonam Verma v. Ashwin Patel (1996), for example, the Supreme Court held that a practitioner registered in one system who treated a patient with the drugs of another, in which he was not qualified, was negligent; the permissions that several state governments have since given to practitioners of the Indian systems to prescribe some modern drugs have been challenged in turn. Ayurvedic medicines are regulated under the Drugs and Cosmetics Act, which was extended to them in the 1960s, and official pharmacopoeias set standards for single drugs and formulations. Rules on good manufacturing practice for Ayurvedic, Siddha and Unani medicines were added to the Drugs and Cosmetics Rules in 2000, and later rules required the testing of products for heavy metals, at least for export. Enforcement of these standards, however, has been uneven.
12.3.4 Industry, Advertising and Regulation¶
The Ayurvedic pharmaceutical industry, which began in the late nineteenth century, has grown into a large sector of the Indian economy, ranging from multinational companies to small local manufacturers. Its products include “classical” formulations made according to the recipes of authoritative texts, and “proprietary” medicines—new combinations sold under brand names—which make up much of the market. Madhulika Banerjee has studied how this industry has reshaped Āyurveda, turning a practice based on individual prescription into one dominated by branded products sold directly to consumers (Banerjee 2009). Advertising has always been central to the industry, and claims to cure serious diseases have repeatedly brought it into conflict with the law of 1954 against objectionable advertisements and with the courts.
The law of 1954 lists a number of serious diseases—among them cancer, diabetes, heart disease, epilepsy and others—for which advertisements claiming a cure are prohibited, whatever the system of medicine. Enforcement has been weak, and in 2024 the Supreme Court of India publicly censured a large Ayurvedic company and the regulatory authorities over misleading advertisements, a case that drew national attention to the problem.
The relationship between Āyurveda and modern medicine within the Indian health system remains contested. Government policy since the 2010s has promoted “integration”—co-location of AYUSH services in hospitals, and in 2020 a notification permitting postgraduates in Āyurvedic surgery to perform a list of common operations. The latter was strongly opposed by the Indian Medical Association, which criticised what it called “mixopathy”. Behind such controversies lie real questions about training, standards, patient safety and the shortage of doctors in rural India.
12.3.5 Medicinal Plants and Conservation¶
Most of the plants used in Āyurvedic and other traditional medicines are still collected from the wild, often by poor and tribal collectors who receive a small share of the final price. Growing demand, in India and abroad, has put a number of species under severe pressure, among them guggulu, kaṭukī and several Himalayan plants also used in Tibetan medicine. The National Medicinal Plants Board, set up in 2000, promotes cultivation and conservation. Sustainable supply is now one of the central practical problems of the industry.
12.3.6 Education and the Place of Sanskrit¶
The Āyurvedic degree course has been a subject of debate since the revival. Its curriculum combines the study of the classical texts—often in Sanskrit, with commentaries—with modern anatomy, physiology, pathology, pharmacology, surgery and obstetrics, and clinical training in both systems. Critics from within the tradition have argued that the modern subjects crowd out the classical learning and produce graduates who are neither good vaidyas nor good doctors; critics from modern medicine argue that the classical subjects teach an outdated theory of the body. Surveys of Āyurvedic graduates have found that many practise modern medicine, wholly or partly, after qualifying. The question of what an Āyurvedic physician should know—and what he or she should be allowed to do—remains unresolved.
12.4 International Recognition and the Global Market¶
The World Health Organization has encouraged member states to make use of traditional medicine in primary health care since the Declaration of Alma-Ata (1978). Its Traditional Medicine Strategy 2014–2023 called on states to integrate traditional medicine into health systems where it is safe and effective, to regulate products and practitioners, and to support research (World Health Organization 2013). WHO has published benchmarks for training and practice in Āyurveda, and in 2022 established its Global Centre for Traditional Medicine at Jamnagar, with funding from the Government of India. The eleventh revision of the International Classification of Diseases includes a supplementary chapter for traditional-medicine diagnoses; its first module covered traditional medicine of Chinese origin, and a second module for Āyurveda, Siddha and Unani was added in 2024. These steps are recognitions of the importance of traditional medicine in health systems; they are not endorsements of the efficacy of particular treatments.
Outside South Asia, Āyurveda became widely known from the 1970s and 1980s, partly through the “Maharishi Ayur-Ved” promoted by the Transcendental Meditation movement and through popular authors in the United States and Europe. It is now part of a large international market in wellness, spa treatments, health tourism and supplements. Regulation varies widely. In the European Union, the Traditional Herbal Medicinal Products Directive of 2004 allows the registration of herbal medicines on the basis of long traditional use and evidence of safety, but most Ayurvedic formulae, especially those containing minerals, do not qualify. In the United Kingdom, Ayurvedic practitioners are not statutorily regulated. In the United States, most Ayurvedic products are sold as dietary supplements, which do not require proof of efficacy before marketing, and the Food and Drug Administration has repeatedly warned consumers and detained imports because of heavy-metal contamination.
12.4.1 Sri Lanka and Nepal¶
In Sri Lanka, Āyurveda has a long history alongside indigenous medicine (deśīya cikitsā) and Siddha and Unani, and the island’s chronicles record royal hospitals from an early period. After independence the Ayurveda Act of 1961 established a department, a medical council and a research institute, and Āyurveda became an official part of the national health system, with its own hospitals and colleges. In Nepal, too, Āyurveda received state patronage, and Kathmandu became an important repository of medical manuscripts: the Kāśyapa Saṃhitā and an early manuscript of the Suśruta Saṃhitā survived there (Chapters 4 and 8). In both countries Āyurveda is practised alongside modern medicine, and the relationship between them raises the same questions as in India.
12.4.2 Health Tourism¶
Since the 1990s, Kerala in particular has promoted Āyurveda as an attraction for foreign and domestic tourists, through resorts, spas and treatment centres offering “rejuvenation” packages and Kerala oil therapies. Health tourism has brought income and employment, but critics have pointed to the commercialisation of a medical tradition, to treatments offered by poorly trained staff, and to the promotion of unproven claims. The state government has introduced classification schemes for Āyurvedic centres in an attempt to maintain standards.
Anthropologists who have studied this “global Ayurveda” have noted how much it differs from practice in India (Wujastyk and Smith 2008). In Europe and North America it is often presented as a gentle, vegetarian, spiritual system of self-care centred on the three doṣas as personality types, on diet and on oil massage, while the surgery, toxicology, meat-based dietetics and mineral pharmacy of the classical and medieval texts are largely absent. In India itself, Āyurveda is practised in government hospitals and dispensaries, in private clinics, by hereditary physicians and by graduates who also prescribe modern drugs; it is used chiefly for chronic illness, digestive complaints, skin diseases and conditions where patients feel that modern medicine has failed them, and most patients use it alongside modern medicine rather than instead of it. Jean Langford’s ethnography of Āyurvedic practitioners in North India shows how they reinterpret the tradition in dialogue with modern medicine and nationalist ideas (Langford 2002).
12.5 What Modern Research Has Shown¶
12.5.1 A Success Story: Rauvolfia¶
The best example of a traditional Indian drug that passed into modern medicine is Rauvolfia serpentina, known in Sanskrit as sarpagandhā and long used in Indian folk and learned medicine, among other things for insanity. In 1931 the Calcutta physicians Gananath Sen and Kartick Chandra Bose reported its use in insanity and high blood pressure, and in 1949 the Bombay cardiologist Rustom Jal Vakil published in the British Heart Journal a study of its effect in essential hypertension that drew international attention (Vakil 1949). Its active alkaloid, reserpine, was isolated in 1952 and became one of the first effective drugs for hypertension and an important tool in the development of psychopharmacology. It is rarely used today, because better-tolerated drugs have replaced it; its side effects include depression. The story shows that traditional knowledge can lead to valuable drugs—and that the path runs through rigorous testing.
12.5.2 The State of the Evidence¶
Since the 1950s a great deal of laboratory and clinical research has been carried out on Ayurvedic plants, formulae and procedures, much of it in India. Reviews of this research reach broadly similar conclusions (Mukherjee and Wahile 2006; Patwardhan et al. 2005). Many plants contain biologically active compounds and show effects in laboratory and animal studies. Clinical trials are fewer; most are small, short, inadequately controlled or unblinded, and few have been replicated independently. Where larger and better trials have been done, results have often been disappointing: the American trial of guggulipid for high cholesterol is an example (Szapary et al. 2003). There are encouraging findings in some areas—for example, the alkaline-thread treatment of fistula-in-ano (Chapter 4)—but for most uses of most Ayurvedic treatments there is not yet good evidence of benefit.
Table 12.2 summarises, in very general terms, the state of the evidence for some of the most widely used Ayurvedic plants and procedures as of the mid-2020s. It is necessarily simplified, and the evidence changes as new studies are published.
| Treatment | Main claimed uses | Clinical evidence and safety |
|---|---|---|
| Rauvolfia (reserpine) | hypertension, psychosis | effective; the active compound became a standard drug, now largely superseded because of side effects |
| Guggulu (guggulipid) | high cholesterol, obesity, arthritis | a good-quality trial found no benefit for cholesterol; skin reactions |
| Turmeric (curcumin) | inflammation, arthritis, many others | many small trials, inconsistent results; poor absorption; liver injury reported with concentrated supplements |
| Aśvagandhā | stress, sleep, vigour | small trials of limited quality; liver injury and thyroid effects reported |
| Brahmī (Bacopa) | memory | small trials with modest effects on some tests |
| Guḍūcī | fever, “immunity” | little good clinical evidence; liver injury reported |
| Triphalā | bowel function | limited evidence of a laxative effect |
| Alkaline thread (kṣārasūtra) | fistula-in-ano | controlled trials comparing it with surgery; used in some surgical units |
| Purification therapies | many chronic diseases | small, mostly uncontrolled studies; risks under-reported |
| Rasaśāstra preparations | many diseases | no adequate trials; heavy-metal toxicity documented |
Some argue that the randomised controlled trial is unsuited to a system that individualises treatment. Trials can, however, be designed to test individualised “whole-system” treatment against a control, and some have been. The real obstacles have been lack of funding for large independent trials, the variability of products, and a tendency in some quarters to treat the antiquity of a remedy as evidence of its value.
12.5.3 Research Ethics and Method¶
Research on traditional medicine raises the same ethical questions as any medical research, and some particular ones. Participants must give informed consent and must not be denied effective treatment for serious conditions. Products tested must be of known composition and free of contamination; several trials of Ayurvedic preparations have used products whose metal content was not measured. Results must be reported in full, including negative results and adverse effects, and trials should be registered in advance—in India, with the Clinical Trials Registry–India, established in 2007. A recurrent problem in the field has been the publication of small positive studies in low-quality journals and the neglect of negative ones, which together give a misleadingly favourable impression.
Some Indian researchers have proposed a “reverse pharmacology” approach: starting from remedies that experienced practitioners believe to be effective, documenting their use carefully, and then testing them clinically and investigating their constituents, rather than screening plants at random in the laboratory. The approach is sensible, provided that the final step—rigorous clinical testing—is not skipped.
12.5.4 Animals and Plants¶
Traditional medicine for animals also continues. Livestock keepers throughout India use local remedies for their cattle, goats and other animals, and “ethnoveterinary” knowledge has been documented by researchers and some development organisations as a cheap and accessible resource, especially where veterinary services are scarce. The classical traditions of horse and elephant medicine (Chapter 5) survive in some places, notably in the care of temple elephants in Kerala. As with human medicine, the value of such remedies has to be established case by case, and some are harmful.
12.5.5 Research Institutions¶
Research on Āyurveda in India is carried out by the Central Council for Research in Ayurvedic Sciences and its network of institutes, by the national institutes and Āyurvedic universities, by laboratories of the Council of Scientific and Industrial Research and the Indian Council of Medical Research, by universities and by industry. A number of journals publish this research, of very variable quality. The quality of much of it has been criticised by both Indian and foreign reviewers: small samples, lack of randomisation and blinding, unregistered trials, poorly characterised products and selective reporting are common. In recent years there have been efforts to improve standards, including the registration of trials, collaboration with institutions of modern medicine, and the publication of protocols in advance.
12.5.6 Constitution and Genetics¶
Research on the genetic and biochemical correlates of prakṛti (Chapter 2) has attracted wide interest under the name “Ayurgenomics”. The early findings are intriguing but preliminary, and they do not yet show that constitutional assessment can guide the treatment of disease (Prasher et al. 2008; Aggarwal et al. 2010).
12.5.7 The COVID-19 Pandemic¶
During the COVID-19 pandemic (2020–2022), Ayurvedic and other traditional preparations were widely promoted in India as “immunity boosters”, and some were advertised as cures. There was no reliable evidence that any of them prevented or treated the disease, and claims of cure led to regulatory and legal action. In the following months Indian hepatologists reported cases of liver injury associated with heavy use of guḍūcī and other herbal products (Nagral et al. 2021). The episode showed both the public trust that traditional medicine enjoys and the dangers of claims that run ahead of evidence.
12.6 Āyurveda and Science¶
The relationship between Āyurveda and modern science has been argued over for more than a century. Three broad positions can be distinguished. The first holds that Āyurveda is a complete science in its own right, with its own epistemology, and that it should be judged by its own standards rather than those of biomedicine. The second holds that Āyurveda is a valuable storehouse of observations and remedies, from which modern science can extract what is useful—particular drugs and practices—by testing them in the ordinary way. The third, now common in Indian policy, calls for “integration” of the two systems in education, research and practice.
Each position has its difficulties. Every medical system has its own concepts, but claims that a treatment works for patients are claims about the world, and the methods for testing them—comparison with a control, measures against bias, honest reporting—are not the property of any one culture; the compendia themselves insist on examination and reasoning. Extracting individual drugs from Āyurveda can neglect the context of diet, regimen and individual assessment in which they were used. And “integration” raises hard questions about which concepts are retained and how disagreements between the systems are to be resolved. The historian’s task is not to settle these debates but to make sure that they are conducted on the basis of an accurate account of what the tradition actually contains.
12.7 Safety¶
This section gathers the practical warnings to which the shorter notes in earlier chapters refer. It is not medical advice for any individual: anyone who is ill should consult a registered medical practitioner.
Health and Safety Note
The single most important fact for a modern reader about Ayurvedic medicines is that “natural” and “traditional” do not mean safe. Tell your doctor and pharmacist about every traditional medicine or supplement you take, avoid products containing metals or minerals, be especially careful in pregnancy and with children, and never stop prescribed treatment without medical advice.
Metals and minerals. Studies of Ayurvedic products sold in the United States and online found lead, mercury or arsenic in about one product in five, often at levels that could exceed safety limits if the products were taken as directed (Saper et al. 2004, 2008), and many cases of lead poisoning from Ayurvedic medicines have been reported, including in pregnant women and children (Centers for Disease Control and Prevention 2004). Products whose ingredients include bhasma, rasa, sindūra or named metals and minerals are best avoided, and products bought online or abroad, whose content is least controlled, call for particular caution. Traditional eye cosmetics and collyria (añjana, surmā, kājal) are often made from lead compounds and are a recognised cause of lead poisoning, especially in children (Section 8.3; Chapter 9).
Poisonous plants. Some classical formulae contain aconite, Datura, nux vomica and other poisonous plants (Section 6.4). Deaths from aconite poisoning after the use of traditional medicines continue to be reported, and classical “purification” does not reliably remove the toxicity of these plants.
Liver injury, interactions and other adverse effects have been reported with several popular herbs and multi-ingredient products, among them aśvagandhā and guḍūcī (Björnsson et al. 2020; Nagral et al. 2021). Herbal medicines can interact with prescribed drugs and affect laboratory tests. Anyone who develops jaundice, abdominal pain, unusual fatigue, numbness or a rash while taking a traditional medicine should stop it and see a doctor.
Purification procedures. Emesis, purgation, enemas, nasal treatments and bloodletting are invasive and carry real risks: dehydration and dangerous disturbances of body salts, inhalation of vomit, injury to the bowel, fainting, bleeding and infection. Large amounts of ghee or oil taken by mouth may harm people with heart, liver or metabolic disease. The procedures are unsuitable for pregnant women, children, the elderly and the frail without assessment by a qualified doctor, and claims that they remove “toxins” have not been substantiated (Chapter 7). Anyone considering them should ask about the qualifications of those treating them and about the risks of the procedures proposed.
Pregnancy, childbirth and infancy. Purification therapies and many herbs are unsafe in pregnancy. Breastfeeding should begin within the first hour after birth, without other feeds; honey must not be given to infants under twelve months, because of the risk of infant botulism; and “gold” and other metal preparations given to infants (suvarṇaprāśana) have no established benefit and carry risks of contamination. Sex-selection is illegal in India. Heavy bleeding, fever or severe pain after childbirth, and any illness in a newborn or young child, need prompt medical attention, and immunisation protects against many of the diseases of childhood (Section 8.4).
Snakebite, animal bites and poisoning. The classical treatments must not be used. The first-aid advice in the World Health Organization’s guidelines for South-East Asia is to keep a person who has been bitten still and calm, to immobilise the bitten limb, to remove rings and tight clothing, not to cut or suck the wound or apply a tourniquet or ice, and to take the person to hospital at once for assessment and, if needed, antivenom (World Health Organization, Regional Office for South-East Asia 2016). A bite or scratch from any animal that may carry rabies should be washed at once with soap and water for about fifteen minutes, and needs urgent medical care for vaccination and, where indicated, immunoglobulin; rabies is almost always fatal once symptoms develop, and no traditional remedy prevents it. For any suspected poisoning, emergency care should be sought at once. Such guidance is revised from time to time, and the current advice of national health authorities should be followed (Section 8.6).
Delay. The greatest harm often comes from delaying effective treatment of serious conditions—tuberculosis and other infections, diabetes, anaemia, jaundice, cancer, heart disease, epilepsy and mental illness—or from stopping a prescribed treatment, for high blood pressure, HIV or any of these conditions, in favour of a traditional remedy. Severe diarrhoea and vomiting need prompt oral rehydration and medical care. Restraint, ritual treatment or purification should never take the place of care for mental illness, epilepsy or alcohol dependence, for which effective treatments exist (Section 8.5).
India has a pharmacovigilance programme for Ayurvedic, Siddha, Unani and homoeopathic medicines through which adverse effects can be reported; reporting them helps others.
12.8 Traditional Knowledge and Intellectual Property¶
In the 1990s Indian scientists and activists challenged patents granted in the United States and Europe on traditional uses of Indian plants. A United States patent on the use of turmeric to heal wounds was revoked in 1997 after the Council of Scientific and Industrial Research showed that the use was already described in Indian texts, and a European patent on a neem-based fungicide was revoked after a long challenge. To prevent such patents, the Government of India created the Traditional Knowledge Digital Library (TKDL) in 2001. It records formulations from the classical texts of Āyurveda, Unani, Siddha and Yoga, translated into English, French, German, Japanese and Spanish and classified in a form usable by patent examiners, and access is given to major patent offices for the purpose of searching “prior art”. The TKDL has been widely praised as a defensive tool, though some have pointed out that it protects the knowledge of the textual traditions more effectively than that of oral, local and tribal ones.
12.9 Conclusion¶
Āyurveda is one of the great medical traditions of the world. Its classical texts are among the most important scientific works of ancient India: rich in observation, systematic in theory, humane in ethics, and remarkable in the range of their concerns, from the regimen of the day to the reconstruction of the nose. Its later history shows a living tradition that absorbed new diseases, new drugs, alchemy and pulse diagnosis, and that adapted to colonial rule, nationalism and the global market. Its historical achievements deserve to be known and studied.
They are honoured best by accuracy. The compendia are not timeless; they were composed and revised over centuries and reflect the societies that produced them. Their theory of the body is not a hidden anticipation of modern science. Their remedies must be judged, like any others, by careful testing, and some of them are dangerous. The tradition’s own founders insisted on examination and reasoning before action. Applied to Āyurveda itself, that principle is the best guide to its future.
Summary
The Āyurveda practised today was made in the last two centuries: by colonial withdrawal and nationalist revival, by print, pharmacies, colleges and committees, by the debate between “pure” and “integrated” teaching, and by the registers, councils and ministry of independent India. Modern research has found biologically active compounds in many of its plants and one outstanding drug in Rauvolfia, but good evidence of benefit for most of its treatments, and evidence of harm from some. The tradition is honoured best by accurate history and by the examination and reasoning that its own founders demanded.
Further Reading¶
On the colonial period see Arnold (Arnold 2000); on the revival and modern Āyurveda, Leslie, Langford, Banerjee and the essays edited by Wujastyk and Smith (Leslie 1976; Langford 2002; Banerjee 2009; Wujastyk and Smith 2008); on the professionalisation of Āyurveda in Bengal, the United Provinces and the Punjab, Mukharji, Berger and Sivaramakrishnan, and on the politics of Āyurvedic education, Brass (Mukharji 2016; Berger 2013; Sivaramakrishnan 2006; Brass 1972); on WHO policy, (World Health Organization 2013); on research, (Patwardhan et al. 2005; Mukherjee and Wahile 2006); on safety, (Saper et al. 2004, 2008).